Project Grant R15GM164647
- Federal Grant Award Summary The University of Missouri System received a $411,454 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through May 31, 2030. The award supports fundamental research focused on controlling drug crystallization, polymorphism, and physicochemical properties using mechanochemistry. The research program investigates the...
- Federal Project Grant Award Summary The University of Missouri System received a $427,526 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This award supports fundamental research to elucidate the mechanisms and functions of bacterial serine-threonine (S/T) and serine-threonine-tyrosine (S/T/Y) kinases in post-translational protein...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $804.8K Project Grant to The Washington University on August 5, 2025, to support fundamental biomedical research under the Biomedical Research and Research Training program (CFDA 93.859). The research project, which extends through May 31, 2030, investigates the metabolic and regulatory mechanisms controlling antibiotic production in filamentous actinobacteria—organisms responsible for producing over...
- Federal Grant Award Summary The University of Missouri System received a $425,974 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, with completion targeted for December 31, 2030. The award funds research to identify and characterize biosynthetic enzymes that convert plant sterols into specialized steroidal compounds, including cardenolides and bufadienolides....
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Missouri System $726,139 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year research project running from July 1, 2025 through May 31, 2030. The project, "Coordination of Complex Dynamics by DNA Manipulating Enzymes," delivers fundamental research services focused on understanding the coordinated dynamics of two...
- Federal Project Grant Award Summary The University of Missouri System received a $386,617 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award supports the Handa Lab's development of catalytic technologies for pharmaceutical synthesis, specifically targeting the creation of safer and more efficient chemical methods for producing...
- Federal Grant Award Summary The University of Missouri System received a $418,822 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on April 5, 2026, with completion targeted for February 28, 2031. This research initiative delivers fundamental scientific investigation advancing mechanistic understanding of biological membranes, addressing two primary research areas: elucidating the...
- Federal Grant Award Summary Michigan Technological University has received a $244,450 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to support computational chemistry research investigating the mechanisms and dynamics of metalloenzymes. The award, effective July 1, 2025, through June 30, 2030, will focus on two primary classes of metal-containing enzymes: zinc(II)-containing matrix...
- Federal Project Grant Award Summary The University of Montana received a $1.184 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for March 31, 2030. The award supports fundamental research focused on developing and characterizing high-valent dinuclear cobalt(IV)-oxo complexes to advance understanding of enzymatic bond activation and...
- Federal Grant Award Summary The University of Missouri System received a $429,797 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 24, 2026, with a completion date of January 31, 2031. This award supports structure-function studies of apolipoprotein B100 (ApoB100), a critical protein involved in lipid and cholesterol transport between the gastrointestinal tract, liver, and...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $528,560 to Missouri University of Science & Technology (NIGMS Biomedical Research and Research Training program, CFDA 93.859) effective June 1, 2026, through May 31, 2029. The project delivers fundamental biochemical and structural research on flavin-dependent N-monooxygenases, enzymes critical to siderophore biosynthesis in pathogenic organisms including Aspergillus fumigatus and Acinetobacter baumannii. The deliverables include detailed biochemical and structural characterization of histamine N-monooxygenases from pathogenic bacteria, identification and characterization of inhibitors targeting ornithine N-monooxygenase (SIDA) from A. fumigatus, and structural elucidation of reaction intermediates. These research products establish foundational knowledge of enzyme mechanisms that could inform future drug development strategies targeting pathogenic iron acquisition pathways and antibiotic resistance. In addition to research outputs, the project serves as an educational platform providing training to undergraduate students in protein chemistry, enzyme characterization, inhibitor design and validation, and structural biochemistry. The research outcomes are intended to enhance understanding of siderophore-mediated iron assimilation mechanisms and generate lead compounds for subsequent therapeutic development, contributing to NIGMS's mission of advancing fundamental biological knowledge relevant to disease diagnosis and treatment innovation.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $528.6k | 5/11/26 |